These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10687260)

  • 1. [The chemoprevention of breast cancer: an evolving reality].
    Lopez M
    Clin Ter; 1999; 150(5):323-5. PubMed ID: 10687260
    [No Abstract]   [Full Text] [Related]  

  • 2. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
    Kondo M; Hoshi SL; Toi M
    Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention clinical trials: it is time to turn success into progress.
    Brown PH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
    Ricart JJ
    Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERMs in chemoprevention of breast cancer.
    Gasco M; Argusti A; Bonanni B; Decensi A
    Eur J Cancer; 2005 Sep; 41(13):1980-9. PubMed ID: 15964182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of endocrine therapy for the treatment and prevention of breast cancer.
    Gradishar WJ; Jordan VC
    Cancer Chemother Biol Response Modif; 2002; 20():227-38. PubMed ID: 12703207
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoprevention of breast cancer with tamoxifen.
    Cuzick J
    IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
    [No Abstract]   [Full Text] [Related]  

  • 11. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention of breast cancer with fenretinide.
    Veronesi U; De Palo G; Costa A; Formelli F; Decensi A
    IARC Sci Publ; 1996; (136):87-94. PubMed ID: 8791119
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention of breast cancer.
    Castrellon AB; Glück S
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel concepts for the chemoprevention of breast cancer through aromatase inhibition.
    Kendall A; Dowsett M
    Endocr Relat Cancer; 2006 Sep; 13(3):827-37. PubMed ID: 16954432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oestrogenic prevention of breast cancer--the make or break point.
    Powles TJ
    Nat Rev Cancer; 2002 Oct; 2(10):787-94. PubMed ID: 12360281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational approaches for the prevention of estrogen receptor-negative breast cancer.
    Li Y; Brown PH
    Eur J Cancer Prev; 2007 Jun; 16(3):203-15. PubMed ID: 17415091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted antiestrogens for the prevention of breast cancer.
    Bentrem DJ; Jordan VC
    Oncol Res; 1999; 11(9):401-7. PubMed ID: 10821534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of breast cancer.
    O'Regan RM
    Cancer Treat Res; 2000; 103():183-207. PubMed ID: 10948447
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women.
    Lawrence JA; Malpas PB; Sigman CC; Kelloff GJ
    J Cell Biochem Suppl; 2000; 34():103-14. PubMed ID: 10762022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
    Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.